
| 1. Leung CH, Lam W, Zhuang WJ, Wong
NS, Yang MS, Fong WF (2001), "PKCdelta-dependent deubiquitination
and stabilization of Gadd45 in A431 cells overexposed to EGF."
Biochem Biophys Res Commun. Jul 13;285(2):283-8.
2. Fong WF, Leung CH, Lam W, Wong NS, Cheng SH (2001), "Epidermal growth factor induces Gadd45 (growth arrest and DNA damage inducible protein) expression in A431 cells." Biochim Biophys Acta. Jan 26;1517(2):250-6. 3. Lam W, Leung C H, Chan H L and Fong W F (2000), "Toxicity and DNA binding of dextrand-oxorubicin conjugates in multidrug resistant KB-VI cell: optimization of dextran size", Anti-Cancer Drugs, 11, 377-384. 4. Chong MW, Gu KD, Lam PK, Yang M, Fong WF (2000), "Study on the cytotoxicity of microcystin-LR on cultured cells." Chemosphere. Jul;41 (1-2):143-7. 5. Cheng SH, Lam W, Lee AS, Fung KP, Wu RS, Fong WF (2000), "Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution." Toxicol Appl Pharmacol. 2000 Apr 15;164(2):134-42. 6. Yang M, Ren LQ, Huang M, Kong RY, Fong WF (1998), "A DNA assay based on fluorescence resonance energy transfer and DNA triplex formation." Anal Biochem. 1998 Jun 1;259(2):272-4. 7. Yang M, Chan HL, Lam W, Fong WF (1998), "Cytotoxicity
and DNA binding characteristics of dextran-conjugated doxorubicins."
Biochim Biophys Acta. 1998 May 8;1380(3):329-35. |
